GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: Cerastecin D is the lead from a novel class of antibacterial compounds that have activity against Acinetobacter baumannii [2]. The structure is claimed in Merck's patent WO2023224893A1 [1]. Functionally it inhibits MsbA, a lipooligosaccharide (LOS) ATP-binding cassette (ABC) transporter that is essential in A. baumannii [3].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Cerastecin D exhibits a narrow-spectrum of antibacterial activity, that is selective for A. baumannii. The MIC90 against carbapenem-resistant A. baumannii (CRAB) clinical isolates is 1.2 μM [3]. |